Ledipasvir 90 mg Sofosbuvir 400 mg Tablet

Product Description

Powerful Antiviral Therapy for HCV

This fixed-dose combination tablet provides effective treatment for chronic Hepatitis C infection in adults, addressing multiple HCV genotypes. The high oral bioavailability ensures efficient absorption, while the convenience of a once-daily oral regimen enhances patient adherence. Suitable for adults diagnosed with genotype 1, 4, 5, or 6 HCV, it aids in reducing viral replication and supports sustained virologic response.


Convenient Dosage and Administration

Ledipasvir-Sofosbuvir comes in an oblong, yellow, film-coated tablet, packaged in bottles of 28 tablets for a full four-week course. Administered orally, one tablet is recommended per day, making it easy to incorporate into daily routines. Its fixed-dose formulation streamlines therapy and improves treatment compliance without the need for additional medications in most cases.


Reliable Quality and Storage

Manufactured under stringent conditions and approved by regulatory authorities, this medicine is supplied through authorized distributors across India. To maintain its efficacy, store it below 30C, protected from moisture and light, and ensure use within its 24-month shelf life. Proper storage helps preserve its stability and ensures maximum therapeutic benefit.